Skip to main content

Published locations for Upadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell Arteritis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Upadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell Arteritis

User login

  • Reset your password
  • /content/upadacitinib-proves-successful-first-jak-inhibitor-trial-giant-cell-arteritis
  • /internalmedicinenews/article/269593/lupus-connective-tissue-diseases/upadacitinib-proves-successful
  • /neurologyreviews/article/269593/lupus-connective-tissue-diseases/upadacitinib-proves-successful
  • /rheumatologynews/article/269593/lupus-connective-tissue-diseases/upadacitinib-proves-successful
  • /rheumatology/article/269593/lupus-connective-tissue-diseases/upadacitinib-proves-successful-first
  • /internalmedicine/article/269593/lupus-connective-tissue-diseases/upadacitinib-proves-successful
  • /neurology/article/269593/lupus-connective-tissue-diseases/upadacitinib-proves-successful-first-jak